Skip to main content

Table 4 Influence of organ manifestation, BMI, age and gender on GHS

From: FeV1 and BMI influence King’s Sarcoidosis Questionnaire score in sarcoidosis patients

 

Estimate

CI

p

VIF

Eye involvement

− 8.490

− 19.15 to 2.17

0.118

1.16

Liver involvement

− 2.417

− 15.76 to 10.92

0.721

1.48

Lung involvement

− 4.078

− 13.58 to 5.42

0.398

1.08

Skin involvement

− 0.164

− 8.73 to 8.40

0.970

1.04

CNS involvement

2.077

− 9.07 to 13.23

0.713

1.11

Renal involvement

− 0.448

− 12.63 to 11.73

0.942

1.04

Heart involvement

− 4.250

− 21.20 to 12.70

0.621

1.04

Bone involvement

− 23.064

− 37.63 to − 8.49

0.002

1.06

Joint

− 12.889

− 28.74 to 2.96

0.110

1.08

Spleen involvement

− 12.804

− 28.66 to 3.05

0.113

1.43

BMI

− 1.076

− 1.61 to − 0.54

0.0001

1.05

Male

− 5.803

− 11.75 to 0.14

0.056

1.09

Age

− 0.004

− 0.23 to 0.22

0.969

1.04

  1. Adjusted R2 = 0.17, p < 0.0001 for the model
  2. Values with statistical significance defined as p < 0.05 were indicated in bold
  3. VIF Variance Inflation Factor